BioSurfaces has been trying to expand it's Bio-Spun™ scaffolds into the organ-on-chip market and have worked with Finnadvance to begin...

In this captivating webcast viewers are taken on a fascinating journey into the cutting-edge world of Bio-Spun™ Scaffolds. Hosted by...

Week 8 – Bottoming Out? Hope all is going well. The summer continues to fly by. As I thought in the previous blog, the summer months...

From Ideas to Innovations: Unraveling the Engineering Design Process In engineering, the problems that we encounter take many forms. They...

Week 7 – Hype vs Substance – Is Selling FOMO the Key to Success? Hope all is going well. June continued to be a productive month, even...

Food and Drug Administration (FDA) Modernization Act 2.0 – What It Means and The Role for Bio-Spun™ 3D Scaffold Technology President...

Building the BioSurfaces Brand Without a Marketing Budget The Problem: I joined the BioSurfaces team a little over 4 years ago charged...

BioSurfaces Receives $1.72 Million Small Business Innovation Research (SBIR) Direct Phase II Grant from National Institutes of Health...

Hope all is going well. We hope that you enjoyed the webcast that Cam from our team put together regarding our 20-year anniversary. If...

Targeted Drug Delivery to Prevent Outflow Complications From Hemodialysis Access Grafts Background End-stage renal disease (ESRD) is a...